Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease
- Conditions
- Stable Coronary Heart Disease
- Interventions
- Dietary Supplement: flavanol-rich drink vs flavanol-free drink
- Registration Number
- NCT02520466
- Lead Sponsor
- University of Zurich
- Brief Summary
The aim of the present study is to investigate whether the ingestion of a cocoa flavanol-containing drink compared to a flavanol-free drink, improves coronary vasomotion and platelet function in patients with overt coronary artery disease acutely (after 2 hours)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
Patients with coronary artery disease undergoing elective coronary angiography with or without the need of coronary intervention
- Age 20 - 80
- Written obtained informed consent
- Acute ST-elevation myocardial infarction
- Acute non-ST-elevation myocardial infarction (enzyme positive)
- Ventricular tachy-arrythmias or AV-Block >I°
- Renal insufficiency (GFR MDRD < 30ml/min) or liver disease (ALT or AST >150 IU)
- Pregnancy
- Known allergy to compounds of cocoa product
- Known allergy to contrast media
- Known allergy to nuts
- Intolerance to coffein and theobromin
- Acute infectious disease
- Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn)
- Participation in another study within the last month
- Concomitant vitamin supplements and herbal remedies, as well as fruit and tea extracts
- No study visits ± 1 week before Eastern, Christmas and New Year holyday (altered eating habits)
- Extreme eating habits (as assessed by a questionnaire)
- Alcohol or drug abuse
- Lactose intolerance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description flavanol-containing drink flavanol-rich drink vs flavanol-free drink flavanol-containing drink flavanol-free drink flavanol-rich drink vs flavanol-free drink flavanol-free drink matched for taste and calories
- Primary Outcome Measures
Name Time Method coronary endothelial function as assessed as response to cold pressor test 2 hours Primary endpoint will be the improvement in coronary endothelial function in response to cold pressor testing (i.e. % reduction in coronary artery constriction compared to baseline) 2h after ingestion of a cocoa flavanol rich-drink or placebo drink, respectively.
In a subset of patients daily consumption of a flavanol-drink will be assessed and outcomes measured after 3-4 weeks.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Cardiovascular Center Cardiology Univeristy Hospital of Zurich
🇨🇭Zurich, Switzerland
Universisty Hospital of Zurich, Cardiovascular Center Cardiology
🇨🇭Zurich, Switzerland